INTIMATION REGARDING CLOSURE OF TRADING WINDOW
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brawn Biotech Ltd has informed the stock exchanges that its trading window for designated persons and their immediate relatives will remain closed from 1st January 2026 until 48 hours after the declaration of unaudited financial results for the quarter ended 31st December 2025. The closure is in line with the company's insider trading code and SEBI's Prohibition of Insider Trading Regulations, 2015. During this period, insiders have been advised not to deal in the company's shares. The date of the board meeting to approve the Q3 results will be announced later.
This is a routine compliance filing and does not directly affect shareholders. It signals that the company's December quarter (Q3 FY26) earnings results will be announced soon, which investors should watch for.